U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550881) titled 'Intranasal Dexmedetomidine for Acute Anxiety State in Adults: A Randomized Trial' on April 19.
Brief Summary: This study employs a randomized, double-blind, placebo-controlled clinical trial design to evaluate the efficacy and safety of dexmedetomidine hydrochloride nasal spray in the treatment of acute anxiety in adults.
Study Protocol: Patients meeting the criteria for acute anxiety who provided informed consent and met the inclusion and exclusion criteria were randomized in a 1:1 ratio to the placebo group or the study drug group and entered the double-blind study. Upon enrollment, baseline assessments were conducted to evaluat...